FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/18/2024
Back to search
Official data from USPTO
EDIGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
03/18/2024
Trademark type
Word
Nice classes
5, 42
Filing date
04/15/2022
Registration date
11/21/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/21/2023
Last transaction
11/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
CN
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
EDIGENE INC.
Representatives
Paulo A. de Almeida Patel & Almeida PC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for medical purposes for the treatment of gene mutation related diseaseshematological diseases and psychiatric and immune system related diseases and disorders; styptic preparations; medicines for human purposesmedicines for the treatment of diabetesobesitycancerviralmetabolicendocrinemusculoskeletaloncological diseasescardiovascular and cerebrovascular diseasesrespiratory diseases and asthmagastrointestinal diseasesgenitourinary diseasesneurological diseasesallergiesheadachesinsomniabacteria-based diseasesocular disorders or diseases; pharmaceutical preparationsantiviralspharmaceutical preparations for suppressing tumorspharmaceutical preparations for the treatment of cancers; stem cells for medical purposes; surgical implants comprised of living tissues; blood productsblood plasmablood for medical purposes; biological preparations for the treatment of cancer; pharmaceutical preparations for activating cellular function; cytostatics for medical purposes; living cells for medical purposes; ophthalmological preparations; pharmaceutical preparations for ophthalmological use; cord blood for medical purposes
Class 42
Biotechnology research; scientific research for medical purposes in the area of cancerous diseases; genetic testing for scientific research purposes; structural and functional analysis of genomes; DNA screening for scientific research purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research services; analysis of the mode of action of chemical combinations on animals; technological research in the field of novel drug development; scientific laboratory services; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; medical research
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2024
FIMP
FINAL DISPOSITION PROCESSED
02/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/21/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/21/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/21/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/16/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/16/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/31/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2023
RFNT
REFUSAL PROCESSED BY IB
04/19/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/29/2023
RFRR
REFUSAL PROCESSED BY MPU
03/29/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/04/2023
CNRT
NON-FINAL ACTION WRITTEN
02/03/2023
DOCK
ASSIGNED TO EXAMINER
02/02/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/28/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/23/2022
Continuous trademark protection
Get notified about every new filing that threatens EDIGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.